Analyst Ratings For NuVasive (NASDAQ:NUVA)
Today, NuVasive (NASDAQ:NUVA) stock was downgraded by Wells Fargo & Co from Outperform to Market Perform with a price target of $65.00.
Some recent analyst ratings include
- 1/17/2018-Wells Fargo & Co was Downgraded by analysts at Wells Fargo & Co from a “Outperform ” rating to a ” Market Perform” rating. They now have a $65.00 price target on the stock.
- 1/9/2018-Piper Jaffray Companies Reiterated Rating of Buy.
- 1/4/2018-Needham & Company LLC Upgrade from a “Underperform ” rating to a ” Buy” rating.
- 12/14/2017-BMO Capital Markets Reiterated Rating of Buy.
- On 8/29/2017 Gregory T Lucier, CEO, bought 2,000 with an average share price of $61.52 per share and the total transaction amounting to $123,040.00.
- On 8/18/2017 Lesley H. Howe, Director, sold 3,970 with an average share price of $64.64 per share and the total transaction amounting to $256,620.80.
- On 8/17/2017 Gregory T Lucier, CEO, bought 5,000 with an average share price of $66.22 per share and the total transaction amounting to $331,100.00.
- On 8/1/2017 Peter Michael Leddy, EVP, bought 7,850 with an average share price of $63.88 per share and the total transaction amounting to $501,458.00.
- On 3/8/2017 Jason Hannon, Insider, sold 24,840 with an average share price of $74.22 per share and the total transaction amounting to $1,843,624.80.
- On 2/14/2017 Lesley H. Howe, Director, sold 6,049 with an average share price of $73.26 per share and the total transaction amounting to $443,149.74.
- On 12/12/2016 Matthew Link, Insider, sold 10,303 with an average share price of $67.99 per share and the total transaction amounting to $700,500.97.
Recent Trading Activity for NuVasive (NASDAQ:NUVA)
Shares of NuVasive closed the previous trading session at 51.21 down -0.78 1.50% with 48.40999984741211 shares trading hands.